Cytosorbents Corp 4
4 · Cytosorbents Corp · Filed Feb 28, 2017
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-24+20,000→ 20,000 totalExercise: $5.60Exp: 2017-02-24→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of CytoSorbents Corporation.